Global Suvorexant Tablet Market Growth 2026-2032
The global Suvorexant Tablet market size is predicted to grow from US$ 357 million in 2025 to US$ 252 million in 2032; it is expected to grow at a CAGR of -5.0% from 2026 to 2032.
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
LP Information, Inc. (LPI) ' newest research report, the ?Suvorexant Tablet Industry Forecast? looks at past sales and reviews total world Suvorexant Tablet sales in 2025, providing a comprehensive analysis by region and market sector of projected Suvorexant Tablet sales for 2026 through 2032. With Suvorexant Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Suvorexant Tablet industry.
This Insight Report provides a comprehensive analysis of the global Suvorexant Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Suvorexant Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Suvorexant Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Suvorexant Tablet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Suvorexant Tablet.
This report presents a comprehensive overview, market shares, and growth opportunities of Suvorexant Tablet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Suvorexant Tablet market?
What factors are driving Suvorexant Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Suvorexant Tablet market opportunities vary by end market size?
How does Suvorexant Tablet break out by Type, by Application?
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
LP Information, Inc. (LPI) ' newest research report, the ?Suvorexant Tablet Industry Forecast? looks at past sales and reviews total world Suvorexant Tablet sales in 2025, providing a comprehensive analysis by region and market sector of projected Suvorexant Tablet sales for 2026 through 2032. With Suvorexant Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Suvorexant Tablet industry.
This Insight Report provides a comprehensive analysis of the global Suvorexant Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Suvorexant Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Suvorexant Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Suvorexant Tablet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Suvorexant Tablet.
This report presents a comprehensive overview, market shares, and growth opportunities of Suvorexant Tablet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 5 mg Tablets
- 10 mg Tablets
- 15 mg Tablets
- 20 mg Tablets
- Other
- Approved Originator Product
- Approved Generic Product
- Generic Under Filing
- Sleep Onset Insomnia
- Sleep Maintenance Insomnia
- Mixed Insomnia
- Clinical Research
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co.
- MSD K.K.
- Merck Sharp & Dohme (Australia)
- Axplora Group
- Zhejiang Huahai Pharmaceutical
- Apino Pharma
- Guangzhou Green Cross Pharmaceutical
- Sandoo Pharmaceuticals and Chemicals
- Nanjing Wedo Pharmatech
- Unibest Industrial
- Taizhou Sci-Healthoo Pharmaceutical Technology
- Shanghai Haoyuan Chemexpress
What is the 10-year outlook for the global Suvorexant Tablet market?
What factors are driving Suvorexant Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Suvorexant Tablet market opportunities vary by end market size?
How does Suvorexant Tablet break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Suvorexant Tablet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Suvorexant Tablet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Suvorexant Tablet by Country/Region, 2021, 2025 & 2032
2.2 Suvorexant Tablet Segment by Type
2.2.1 5 mg Tablets
2.2.2 10 mg Tablets
2.2.3 15 mg Tablets
2.2.4 20 mg Tablets
2.2.5 Other
2.2.6 Suvorexant Tablet Sales by Type
2.2.6.1 Global Suvorexant Tablet Sales Market Share by Type (2021-2026)
2.2.6.2 Global Suvorexant Tablet Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Suvorexant Tablet Sale Price by Type (2021-2026)
2.3 Suvorexant Tablet Segment by Regulatory Status
2.3.1 Approved Originator Product
2.3.2 Approved Generic Product
2.3.3 Generic Under Filing
2.3.4 Suvorexant Tablet Sales by Regulatory Status
2.3.4.1 Global Suvorexant Tablet Sales Market Share by Regulatory Status (2021-2026)
2.3.4.2 Global Suvorexant Tablet Revenue and Market Share by Regulatory Status (2021-2026)
2.3.4.3 Global Suvorexant Tablet Sale Price by Regulatory Status (2021-2026)
2.4 Suvorexant Tablet Segment by Application
2.4.1 Sleep Onset Insomnia
2.4.2 Sleep Maintenance Insomnia
2.4.3 Mixed Insomnia
2.4.4 Clinical Research
2.4.5 Other
2.4.6 Suvorexant Tablet Sales by Application
2.4.6.1 Global Suvorexant Tablet Sale Market Share by Application (2021-2026)
2.4.6.2 Global Suvorexant Tablet Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Suvorexant Tablet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Suvorexant Tablet Breakdown Data by Company
3.1.1 Global Suvorexant Tablet Annual Sales by Company (2021-2026)
3.1.2 Global Suvorexant Tablet Sales Market Share by Company (2021-2026)
3.2 Global Suvorexant Tablet Annual Revenue by Company (2021-2026)
3.2.1 Global Suvorexant Tablet Revenue by Company (2021-2026)
3.2.2 Global Suvorexant Tablet Revenue Market Share by Company (2021-2026)
3.3 Global Suvorexant Tablet Sale Price by Company
3.4 Key Manufacturers Suvorexant Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Suvorexant Tablet Product Location Distribution
3.4.2 Players Suvorexant Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SUVOREXANT TABLET BY GEOGRAPHIC REGION
4.1 World Historic Suvorexant Tablet Market Size by Geographic Region (2021-2026)
4.1.1 Global Suvorexant Tablet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Suvorexant Tablet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Suvorexant Tablet Market Size by Country/Region (2021-2026)
4.2.1 Global Suvorexant Tablet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Suvorexant Tablet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Suvorexant Tablet Sales Growth
4.4 APAC Suvorexant Tablet Sales Growth
4.5 Europe Suvorexant Tablet Sales Growth
4.6 Middle East & Africa Suvorexant Tablet Sales Growth
5 AMERICAS
5.1 Americas Suvorexant Tablet Sales by Country
5.1.1 Americas Suvorexant Tablet Sales by Country (2021-2026)
5.1.2 Americas Suvorexant Tablet Revenue by Country (2021-2026)
5.2 Americas Suvorexant Tablet Sales by Type (2021-2026)
5.3 Americas Suvorexant Tablet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Suvorexant Tablet Sales by Region
6.1.1 APAC Suvorexant Tablet Sales by Region (2021-2026)
6.1.2 APAC Suvorexant Tablet Revenue by Region (2021-2026)
6.2 APAC Suvorexant Tablet Sales by Type (2021-2026)
6.3 APAC Suvorexant Tablet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Suvorexant Tablet by Country
7.1.1 Europe Suvorexant Tablet Sales by Country (2021-2026)
7.1.2 Europe Suvorexant Tablet Revenue by Country (2021-2026)
7.2 Europe Suvorexant Tablet Sales by Type (2021-2026)
7.3 Europe Suvorexant Tablet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Suvorexant Tablet by Country
8.1.1 Middle East & Africa Suvorexant Tablet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Suvorexant Tablet Revenue by Country (2021-2026)
8.2 Middle East & Africa Suvorexant Tablet Sales by Type (2021-2026)
8.3 Middle East & Africa Suvorexant Tablet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Suvorexant Tablet
10.3 Manufacturing Process Analysis of Suvorexant Tablet
10.4 Industry Chain Structure of Suvorexant Tablet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Suvorexant Tablet Distributors
11.3 Suvorexant Tablet Customer
12 WORLD FORECAST REVIEW FOR SUVOREXANT TABLET BY GEOGRAPHIC REGION
12.1 Global Suvorexant Tablet Market Size Forecast by Region
12.1.1 Global Suvorexant Tablet Forecast by Region (2027-2032)
12.1.2 Global Suvorexant Tablet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Suvorexant Tablet Forecast by Type (2027-2032)
12.7 Global Suvorexant Tablet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Suvorexant Tablet Product Portfolios and Specifications
13.1.3 Merck & Co. Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 MSD K.K.
13.2.1 MSD K.K. Company Information
13.2.2 MSD K.K. Suvorexant Tablet Product Portfolios and Specifications
13.2.3 MSD K.K. Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD K.K. Main Business Overview
13.2.5 MSD K.K. Latest Developments
13.3 Merck Sharp & Dohme (Australia)
13.3.1 Merck Sharp & Dohme (Australia) Company Information
13.3.2 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product Portfolios and Specifications
13.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Sharp & Dohme (Australia) Main Business Overview
13.3.5 Merck Sharp & Dohme (Australia) Latest Developments
13.4 Axplora Group
13.4.1 Axplora Group Company Information
13.4.2 Axplora Group Suvorexant Tablet Product Portfolios and Specifications
13.4.3 Axplora Group Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Axplora Group Main Business Overview
13.4.5 Axplora Group Latest Developments
13.5 Zhejiang Huahai Pharmaceutical
13.5.1 Zhejiang Huahai Pharmaceutical Company Information
13.5.2 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product Portfolios and Specifications
13.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.5.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.6 Apino Pharma
13.6.1 Apino Pharma Company Information
13.6.2 Apino Pharma Suvorexant Tablet Product Portfolios and Specifications
13.6.3 Apino Pharma Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Apino Pharma Main Business Overview
13.6.5 Apino Pharma Latest Developments
13.7 Guangzhou Green Cross Pharmaceutical
13.7.1 Guangzhou Green Cross Pharmaceutical Company Information
13.7.2 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product Portfolios and Specifications
13.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Guangzhou Green Cross Pharmaceutical Main Business Overview
13.7.5 Guangzhou Green Cross Pharmaceutical Latest Developments
13.8 Sandoo Pharmaceuticals and Chemicals
13.8.1 Sandoo Pharmaceuticals and Chemicals Company Information
13.8.2 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product Portfolios and Specifications
13.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sandoo Pharmaceuticals and Chemicals Main Business Overview
13.8.5 Sandoo Pharmaceuticals and Chemicals Latest Developments
13.9 Nanjing Wedo Pharmatech
13.9.1 Nanjing Wedo Pharmatech Company Information
13.9.2 Nanjing Wedo Pharmatech Suvorexant Tablet Product Portfolios and Specifications
13.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nanjing Wedo Pharmatech Main Business Overview
13.9.5 Nanjing Wedo Pharmatech Latest Developments
13.10 Unibest Industrial
13.10.1 Unibest Industrial Company Information
13.10.2 Unibest Industrial Suvorexant Tablet Product Portfolios and Specifications
13.10.3 Unibest Industrial Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Unibest Industrial Main Business Overview
13.10.5 Unibest Industrial Latest Developments
13.11 Taizhou Sci-Healthoo Pharmaceutical Technology
13.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Company Information
13.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product Portfolios and Specifications
13.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Main Business Overview
13.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Latest Developments
13.12 Shanghai Haoyuan Chemexpress
13.12.1 Shanghai Haoyuan Chemexpress Company Information
13.12.2 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product Portfolios and Specifications
13.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai Haoyuan Chemexpress Main Business Overview
13.12.5 Shanghai Haoyuan Chemexpress Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Suvorexant Tablet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Suvorexant Tablet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Suvorexant Tablet by Country/Region, 2021, 2025 & 2032
2.2 Suvorexant Tablet Segment by Type
2.2.1 5 mg Tablets
2.2.2 10 mg Tablets
2.2.3 15 mg Tablets
2.2.4 20 mg Tablets
2.2.5 Other
2.2.6 Suvorexant Tablet Sales by Type
2.2.6.1 Global Suvorexant Tablet Sales Market Share by Type (2021-2026)
2.2.6.2 Global Suvorexant Tablet Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Suvorexant Tablet Sale Price by Type (2021-2026)
2.3 Suvorexant Tablet Segment by Regulatory Status
2.3.1 Approved Originator Product
2.3.2 Approved Generic Product
2.3.3 Generic Under Filing
2.3.4 Suvorexant Tablet Sales by Regulatory Status
2.3.4.1 Global Suvorexant Tablet Sales Market Share by Regulatory Status (2021-2026)
2.3.4.2 Global Suvorexant Tablet Revenue and Market Share by Regulatory Status (2021-2026)
2.3.4.3 Global Suvorexant Tablet Sale Price by Regulatory Status (2021-2026)
2.4 Suvorexant Tablet Segment by Application
2.4.1 Sleep Onset Insomnia
2.4.2 Sleep Maintenance Insomnia
2.4.3 Mixed Insomnia
2.4.4 Clinical Research
2.4.5 Other
2.4.6 Suvorexant Tablet Sales by Application
2.4.6.1 Global Suvorexant Tablet Sale Market Share by Application (2021-2026)
2.4.6.2 Global Suvorexant Tablet Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Suvorexant Tablet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Suvorexant Tablet Breakdown Data by Company
3.1.1 Global Suvorexant Tablet Annual Sales by Company (2021-2026)
3.1.2 Global Suvorexant Tablet Sales Market Share by Company (2021-2026)
3.2 Global Suvorexant Tablet Annual Revenue by Company (2021-2026)
3.2.1 Global Suvorexant Tablet Revenue by Company (2021-2026)
3.2.2 Global Suvorexant Tablet Revenue Market Share by Company (2021-2026)
3.3 Global Suvorexant Tablet Sale Price by Company
3.4 Key Manufacturers Suvorexant Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Suvorexant Tablet Product Location Distribution
3.4.2 Players Suvorexant Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SUVOREXANT TABLET BY GEOGRAPHIC REGION
4.1 World Historic Suvorexant Tablet Market Size by Geographic Region (2021-2026)
4.1.1 Global Suvorexant Tablet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Suvorexant Tablet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Suvorexant Tablet Market Size by Country/Region (2021-2026)
4.2.1 Global Suvorexant Tablet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Suvorexant Tablet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Suvorexant Tablet Sales Growth
4.4 APAC Suvorexant Tablet Sales Growth
4.5 Europe Suvorexant Tablet Sales Growth
4.6 Middle East & Africa Suvorexant Tablet Sales Growth
5 AMERICAS
5.1 Americas Suvorexant Tablet Sales by Country
5.1.1 Americas Suvorexant Tablet Sales by Country (2021-2026)
5.1.2 Americas Suvorexant Tablet Revenue by Country (2021-2026)
5.2 Americas Suvorexant Tablet Sales by Type (2021-2026)
5.3 Americas Suvorexant Tablet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Suvorexant Tablet Sales by Region
6.1.1 APAC Suvorexant Tablet Sales by Region (2021-2026)
6.1.2 APAC Suvorexant Tablet Revenue by Region (2021-2026)
6.2 APAC Suvorexant Tablet Sales by Type (2021-2026)
6.3 APAC Suvorexant Tablet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Suvorexant Tablet by Country
7.1.1 Europe Suvorexant Tablet Sales by Country (2021-2026)
7.1.2 Europe Suvorexant Tablet Revenue by Country (2021-2026)
7.2 Europe Suvorexant Tablet Sales by Type (2021-2026)
7.3 Europe Suvorexant Tablet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Suvorexant Tablet by Country
8.1.1 Middle East & Africa Suvorexant Tablet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Suvorexant Tablet Revenue by Country (2021-2026)
8.2 Middle East & Africa Suvorexant Tablet Sales by Type (2021-2026)
8.3 Middle East & Africa Suvorexant Tablet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Suvorexant Tablet
10.3 Manufacturing Process Analysis of Suvorexant Tablet
10.4 Industry Chain Structure of Suvorexant Tablet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Suvorexant Tablet Distributors
11.3 Suvorexant Tablet Customer
12 WORLD FORECAST REVIEW FOR SUVOREXANT TABLET BY GEOGRAPHIC REGION
12.1 Global Suvorexant Tablet Market Size Forecast by Region
12.1.1 Global Suvorexant Tablet Forecast by Region (2027-2032)
12.1.2 Global Suvorexant Tablet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Suvorexant Tablet Forecast by Type (2027-2032)
12.7 Global Suvorexant Tablet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Suvorexant Tablet Product Portfolios and Specifications
13.1.3 Merck & Co. Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 MSD K.K.
13.2.1 MSD K.K. Company Information
13.2.2 MSD K.K. Suvorexant Tablet Product Portfolios and Specifications
13.2.3 MSD K.K. Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD K.K. Main Business Overview
13.2.5 MSD K.K. Latest Developments
13.3 Merck Sharp & Dohme (Australia)
13.3.1 Merck Sharp & Dohme (Australia) Company Information
13.3.2 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product Portfolios and Specifications
13.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Sharp & Dohme (Australia) Main Business Overview
13.3.5 Merck Sharp & Dohme (Australia) Latest Developments
13.4 Axplora Group
13.4.1 Axplora Group Company Information
13.4.2 Axplora Group Suvorexant Tablet Product Portfolios and Specifications
13.4.3 Axplora Group Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Axplora Group Main Business Overview
13.4.5 Axplora Group Latest Developments
13.5 Zhejiang Huahai Pharmaceutical
13.5.1 Zhejiang Huahai Pharmaceutical Company Information
13.5.2 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product Portfolios and Specifications
13.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.5.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.6 Apino Pharma
13.6.1 Apino Pharma Company Information
13.6.2 Apino Pharma Suvorexant Tablet Product Portfolios and Specifications
13.6.3 Apino Pharma Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Apino Pharma Main Business Overview
13.6.5 Apino Pharma Latest Developments
13.7 Guangzhou Green Cross Pharmaceutical
13.7.1 Guangzhou Green Cross Pharmaceutical Company Information
13.7.2 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product Portfolios and Specifications
13.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Guangzhou Green Cross Pharmaceutical Main Business Overview
13.7.5 Guangzhou Green Cross Pharmaceutical Latest Developments
13.8 Sandoo Pharmaceuticals and Chemicals
13.8.1 Sandoo Pharmaceuticals and Chemicals Company Information
13.8.2 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product Portfolios and Specifications
13.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sandoo Pharmaceuticals and Chemicals Main Business Overview
13.8.5 Sandoo Pharmaceuticals and Chemicals Latest Developments
13.9 Nanjing Wedo Pharmatech
13.9.1 Nanjing Wedo Pharmatech Company Information
13.9.2 Nanjing Wedo Pharmatech Suvorexant Tablet Product Portfolios and Specifications
13.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nanjing Wedo Pharmatech Main Business Overview
13.9.5 Nanjing Wedo Pharmatech Latest Developments
13.10 Unibest Industrial
13.10.1 Unibest Industrial Company Information
13.10.2 Unibest Industrial Suvorexant Tablet Product Portfolios and Specifications
13.10.3 Unibest Industrial Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Unibest Industrial Main Business Overview
13.10.5 Unibest Industrial Latest Developments
13.11 Taizhou Sci-Healthoo Pharmaceutical Technology
13.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Company Information
13.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product Portfolios and Specifications
13.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Main Business Overview
13.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Latest Developments
13.12 Shanghai Haoyuan Chemexpress
13.12.1 Shanghai Haoyuan Chemexpress Company Information
13.12.2 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product Portfolios and Specifications
13.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shanghai Haoyuan Chemexpress Main Business Overview
13.12.5 Shanghai Haoyuan Chemexpress Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. SuvorexantTablet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. SuvorexantTablet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5 mgTablets
Table 4. Major Players of 10 mgTablets
Table 5. Major Players of 15 mgTablets
Table 6. Major Players of 20 mgTablets
Table 7. Major Players of Other
Table 8. Global SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 9. Global SuvorexantTablet Sales Market Share by Type (2021-2026)
Table 10. Global SuvorexantTablet Revenue by Type (2021-2026) & ($ million)
Table 11. Global SuvorexantTablet Revenue Market Share by Type (2021-2026)
Table 12. Global SuvorexantTablet Sale Price by Type (2021-2026) & (US$/Tablet)
Table 13. Major Players of Approved Originator Product
Table 14. Major Players of Approved Generic Product
Table 15. Major Players of Generic Under Filing
Table 16. Global SuvorexantTablet Sales by Regulatory Status (2021-2026) & (KTablets)
Table 17. Global SuvorexantTablet Sales Market Share by Regulatory Status (2021-2026)
Table 18. Global SuvorexantTablet Revenue by Regulatory Status (2021-2026) & ($ million)
Table 19. Global SuvorexantTablet Revenue Market Share by Regulatory Status (2021-2026)
Table 20. Global SuvorexantTablet Sale Price by Regulatory Status (2021-2026) & (US$/Tablet)
Table 21. Global SuvorexantTablet Sale by Application (2021-2026) & (KTablets)
Table 22. Global SuvorexantTablet Sale Market Share by Application (2021-2026)
Table 23. Global SuvorexantTablet Revenue by Application (2021-2026) & ($ million)
Table 24. Global SuvorexantTablet Revenue Market Share by Application (2021-2026)
Table 25. Global SuvorexantTablet Sale Price by Application (2021-2026) & (US$/Tablet)
Table 26. Global SuvorexantTablet Sales by Company (2021-2026) & (KTablets)
Table 27. Global SuvorexantTablet Sales Market Share by Company (2021-2026)
Table 28. Global SuvorexantTablet Revenue by Company (2021-2026) & ($ millions)
Table 29. Global SuvorexantTablet Revenue Market Share by Company (2021-2026)
Table 30. Global SuvorexantTablet Sale Price by Company (2021-2026) & (US$/Tablet)
Table 31. Key Manufacturers SuvorexantTablet Producing Area Distribution and Sales Area
Table 32. Players SuvorexantTablet Products Offered
Table 33. SuvorexantTablet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global SuvorexantTablet Sales by Geographic Region (2021-2026) & (KTablets)
Table 37. Global SuvorexantTablet Sales Market Share Geographic Region (2021-2026)
Table 38. Global SuvorexantTablet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global SuvorexantTablet Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global SuvorexantTablet Sales by Country/Region (2021-2026) & (KTablets)
Table 41. Global SuvorexantTablet Sales Market Share by Country/Region (2021-2026)
Table 42. Global SuvorexantTablet Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global SuvorexantTablet Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 45. Americas SuvorexantTablet Sales Market Share by Country (2021-2026)
Table 46. Americas SuvorexantTablet Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 48. Americas SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 49. APAC SuvorexantTablet Sales by Region (2021-2026) & (KTablets)
Table 50. APAC SuvorexantTablet Sales Market Share by Region (2021-2026)
Table 51. APAC SuvorexantTablet Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 53. APAC SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 54. Europe SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 55. Europe SuvorexantTablet Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 57. Europe SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 58. Middle East & Africa SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 59. Middle East & Africa SuvorexantTablet Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 61. Middle East & Africa SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 62. Key Market Drivers & Growth Opportunities of SuvorexantTablet
Table 63. Key Market Challenges & Risks of SuvorexantTablet
Table 64. Key Industry Trends of SuvorexantTablet
Table 65. SuvorexantTablet Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. SuvorexantTablet Distributors List
Table 68. SuvorexantTablet Customer List
Table 69. Global SuvorexantTablet Sales Forecast by Region (2027-2032) & (KTablets)
Table 70. Global SuvorexantTablet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 72. Americas SuvorexantTablet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC SuvorexantTablet Sales Forecast by Region (2027-2032) & (KTablets)
Table 74. APAC SuvorexantTablet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 76. Europe SuvorexantTablet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 78. Middle East & Africa SuvorexantTablet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global SuvorexantTablet Sales Forecast by Type (2027-2032) & (KTablets)
Table 80. Global SuvorexantTablet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global SuvorexantTablet Sales Forecast by Application (2027-2032) & (KTablets)
Table 82. Global SuvorexantTablet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. Merck & Co. Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. SuvorexantTablet Product Portfolios and Specifications
Table 85. Merck & Co. SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 86. Merck & Co. Main Business
Table 87. Merck & Co. Latest Developments
Table 88. MSD K.K. Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 89. MSD K.K. SuvorexantTablet Product Portfolios and Specifications
Table 90. MSD K.K. SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 91. MSD K.K. Main Business
Table 92. MSD K.K. Latest Developments
Table 93. Merck Sharp & Dohme (Australia) Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Sharp & Dohme (Australia) SuvorexantTablet Product Portfolios and Specifications
Table 95. Merck Sharp & Dohme (Australia) SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 96. Merck Sharp & Dohme (Australia) Main Business
Table 97. Merck Sharp & Dohme (Australia) Latest Developments
Table 98. Axplora Group Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 99. Axplora Group SuvorexantTablet Product Portfolios and Specifications
Table 100. Axplora Group SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 101. Axplora Group Main Business
Table 102. Axplora Group Latest Developments
Table 103. Zhejiang Huahai Pharmaceutical Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 104. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product Portfolios and Specifications
Table 105. Zhejiang Huahai Pharmaceutical SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 106. Zhejiang Huahai Pharmaceutical Main Business
Table 107. Zhejiang Huahai Pharmaceutical Latest Developments
Table 108. Apino Pharma Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 109. Apino Pharma SuvorexantTablet Product Portfolios and Specifications
Table 110. Apino Pharma SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 111. Apino Pharma Main Business
Table 112. Apino Pharma Latest Developments
Table 113. Guangzhou Green Cross Pharmaceutical Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 114. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product Portfolios and Specifications
Table 115. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 116. Guangzhou Green Cross Pharmaceutical Main Business
Table 117. Guangzhou Green Cross Pharmaceutical Latest Developments
Table 118. Sandoo Pharmaceuticals and Chemicals Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product Portfolios and Specifications
Table 120. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 121. Sandoo Pharmaceuticals and Chemicals Main Business
Table 122. Sandoo Pharmaceuticals and Chemicals Latest Developments
Table 123. Nanjing Wedo Pharmatech Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 124. Nanjing Wedo Pharmatech SuvorexantTablet Product Portfolios and Specifications
Table 125. Nanjing Wedo Pharmatech SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 126. Nanjing Wedo Pharmatech Main Business
Table 127. Nanjing Wedo Pharmatech Latest Developments
Table 128. Unibest Industrial Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 129. Unibest Industrial SuvorexantTablet Product Portfolios and Specifications
Table 130. Unibest Industrial SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 131. Unibest Industrial Main Business
Table 132. Unibest Industrial Latest Developments
Table 133. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 134. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product Portfolios and Specifications
Table 135. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 136. Taizhou Sci-Healthoo Pharmaceutical Technology Main Business
Table 137. Taizhou Sci-Healthoo Pharmaceutical Technology Latest Developments
Table 138. Shanghai Haoyuan Chemexpress Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai Haoyuan Chemexpress SuvorexantTablet Product Portfolios and Specifications
Table 140. Shanghai Haoyuan Chemexpress SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 141. Shanghai Haoyuan Chemexpress Main Business
Table 142. Shanghai Haoyuan Chemexpress Latest Developments
Table 1. SuvorexantTablet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. SuvorexantTablet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5 mgTablets
Table 4. Major Players of 10 mgTablets
Table 5. Major Players of 15 mgTablets
Table 6. Major Players of 20 mgTablets
Table 7. Major Players of Other
Table 8. Global SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 9. Global SuvorexantTablet Sales Market Share by Type (2021-2026)
Table 10. Global SuvorexantTablet Revenue by Type (2021-2026) & ($ million)
Table 11. Global SuvorexantTablet Revenue Market Share by Type (2021-2026)
Table 12. Global SuvorexantTablet Sale Price by Type (2021-2026) & (US$/Tablet)
Table 13. Major Players of Approved Originator Product
Table 14. Major Players of Approved Generic Product
Table 15. Major Players of Generic Under Filing
Table 16. Global SuvorexantTablet Sales by Regulatory Status (2021-2026) & (KTablets)
Table 17. Global SuvorexantTablet Sales Market Share by Regulatory Status (2021-2026)
Table 18. Global SuvorexantTablet Revenue by Regulatory Status (2021-2026) & ($ million)
Table 19. Global SuvorexantTablet Revenue Market Share by Regulatory Status (2021-2026)
Table 20. Global SuvorexantTablet Sale Price by Regulatory Status (2021-2026) & (US$/Tablet)
Table 21. Global SuvorexantTablet Sale by Application (2021-2026) & (KTablets)
Table 22. Global SuvorexantTablet Sale Market Share by Application (2021-2026)
Table 23. Global SuvorexantTablet Revenue by Application (2021-2026) & ($ million)
Table 24. Global SuvorexantTablet Revenue Market Share by Application (2021-2026)
Table 25. Global SuvorexantTablet Sale Price by Application (2021-2026) & (US$/Tablet)
Table 26. Global SuvorexantTablet Sales by Company (2021-2026) & (KTablets)
Table 27. Global SuvorexantTablet Sales Market Share by Company (2021-2026)
Table 28. Global SuvorexantTablet Revenue by Company (2021-2026) & ($ millions)
Table 29. Global SuvorexantTablet Revenue Market Share by Company (2021-2026)
Table 30. Global SuvorexantTablet Sale Price by Company (2021-2026) & (US$/Tablet)
Table 31. Key Manufacturers SuvorexantTablet Producing Area Distribution and Sales Area
Table 32. Players SuvorexantTablet Products Offered
Table 33. SuvorexantTablet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Market M&A Activity & Strategy
Table 36. Global SuvorexantTablet Sales by Geographic Region (2021-2026) & (KTablets)
Table 37. Global SuvorexantTablet Sales Market Share Geographic Region (2021-2026)
Table 38. Global SuvorexantTablet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 39. Global SuvorexantTablet Revenue Market Share by Geographic Region (2021-2026)
Table 40. Global SuvorexantTablet Sales by Country/Region (2021-2026) & (KTablets)
Table 41. Global SuvorexantTablet Sales Market Share by Country/Region (2021-2026)
Table 42. Global SuvorexantTablet Revenue by Country/Region (2021-2026) & ($ millions)
Table 43. Global SuvorexantTablet Revenue Market Share by Country/Region (2021-2026)
Table 44. Americas SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 45. Americas SuvorexantTablet Sales Market Share by Country (2021-2026)
Table 46. Americas SuvorexantTablet Revenue by Country (2021-2026) & ($ millions)
Table 47. Americas SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 48. Americas SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 49. APAC SuvorexantTablet Sales by Region (2021-2026) & (KTablets)
Table 50. APAC SuvorexantTablet Sales Market Share by Region (2021-2026)
Table 51. APAC SuvorexantTablet Revenue by Region (2021-2026) & ($ millions)
Table 52. APAC SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 53. APAC SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 54. Europe SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 55. Europe SuvorexantTablet Revenue by Country (2021-2026) & ($ millions)
Table 56. Europe SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 57. Europe SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 58. Middle East & Africa SuvorexantTablet Sales by Country (2021-2026) & (KTablets)
Table 59. Middle East & Africa SuvorexantTablet Revenue Market Share by Country (2021-2026)
Table 60. Middle East & Africa SuvorexantTablet Sales by Type (2021-2026) & (KTablets)
Table 61. Middle East & Africa SuvorexantTablet Sales by Application (2021-2026) & (KTablets)
Table 62. Key Market Drivers & Growth Opportunities of SuvorexantTablet
Table 63. Key Market Challenges & Risks of SuvorexantTablet
Table 64. Key Industry Trends of SuvorexantTablet
Table 65. SuvorexantTablet Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. SuvorexantTablet Distributors List
Table 68. SuvorexantTablet Customer List
Table 69. Global SuvorexantTablet Sales Forecast by Region (2027-2032) & (KTablets)
Table 70. Global SuvorexantTablet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 71. Americas SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 72. Americas SuvorexantTablet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. APAC SuvorexantTablet Sales Forecast by Region (2027-2032) & (KTablets)
Table 74. APAC SuvorexantTablet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Europe SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 76. Europe SuvorexantTablet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Middle East & Africa SuvorexantTablet Sales Forecast by Country (2027-2032) & (KTablets)
Table 78. Middle East & Africa SuvorexantTablet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Global SuvorexantTablet Sales Forecast by Type (2027-2032) & (KTablets)
Table 80. Global SuvorexantTablet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 81. Global SuvorexantTablet Sales Forecast by Application (2027-2032) & (KTablets)
Table 82. Global SuvorexantTablet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 83. Merck & Co. Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. SuvorexantTablet Product Portfolios and Specifications
Table 85. Merck & Co. SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 86. Merck & Co. Main Business
Table 87. Merck & Co. Latest Developments
Table 88. MSD K.K. Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 89. MSD K.K. SuvorexantTablet Product Portfolios and Specifications
Table 90. MSD K.K. SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 91. MSD K.K. Main Business
Table 92. MSD K.K. Latest Developments
Table 93. Merck Sharp & Dohme (Australia) Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Sharp & Dohme (Australia) SuvorexantTablet Product Portfolios and Specifications
Table 95. Merck Sharp & Dohme (Australia) SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 96. Merck Sharp & Dohme (Australia) Main Business
Table 97. Merck Sharp & Dohme (Australia) Latest Developments
Table 98. Axplora Group Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 99. Axplora Group SuvorexantTablet Product Portfolios and Specifications
Table 100. Axplora Group SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 101. Axplora Group Main Business
Table 102. Axplora Group Latest Developments
Table 103. Zhejiang Huahai Pharmaceutical Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 104. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product Portfolios and Specifications
Table 105. Zhejiang Huahai Pharmaceutical SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 106. Zhejiang Huahai Pharmaceutical Main Business
Table 107. Zhejiang Huahai Pharmaceutical Latest Developments
Table 108. Apino Pharma Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 109. Apino Pharma SuvorexantTablet Product Portfolios and Specifications
Table 110. Apino Pharma SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 111. Apino Pharma Main Business
Table 112. Apino Pharma Latest Developments
Table 113. Guangzhou Green Cross Pharmaceutical Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 114. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product Portfolios and Specifications
Table 115. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 116. Guangzhou Green Cross Pharmaceutical Main Business
Table 117. Guangzhou Green Cross Pharmaceutical Latest Developments
Table 118. Sandoo Pharmaceuticals and Chemicals Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product Portfolios and Specifications
Table 120. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 121. Sandoo Pharmaceuticals and Chemicals Main Business
Table 122. Sandoo Pharmaceuticals and Chemicals Latest Developments
Table 123. Nanjing Wedo Pharmatech Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 124. Nanjing Wedo Pharmatech SuvorexantTablet Product Portfolios and Specifications
Table 125. Nanjing Wedo Pharmatech SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 126. Nanjing Wedo Pharmatech Main Business
Table 127. Nanjing Wedo Pharmatech Latest Developments
Table 128. Unibest Industrial Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 129. Unibest Industrial SuvorexantTablet Product Portfolios and Specifications
Table 130. Unibest Industrial SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 131. Unibest Industrial Main Business
Table 132. Unibest Industrial Latest Developments
Table 133. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 134. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product Portfolios and Specifications
Table 135. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 136. Taizhou Sci-Healthoo Pharmaceutical Technology Main Business
Table 137. Taizhou Sci-Healthoo Pharmaceutical Technology Latest Developments
Table 138. Shanghai Haoyuan Chemexpress Basic Information, SuvorexantTablet Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai Haoyuan Chemexpress SuvorexantTablet Product Portfolios and Specifications
Table 140. Shanghai Haoyuan Chemexpress SuvorexantTablet Sales (KTablets), Revenue ($ Million), Price (US$/Tablet) and Gross Margin (2021-2026)
Table 141. Shanghai Haoyuan Chemexpress Main Business
Table 142. Shanghai Haoyuan Chemexpress Latest Developments
LIST OF FIGURES
Figure 1. Picture of SuvorexantTablet
Figure 2. SuvorexantTablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SuvorexantTablet Sales Growth Rate 2021-2032 (KTablets)
Figure 7. Global SuvorexantTablet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. SuvorexantTablet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. SuvorexantTablet Sales Market Share by Country/Region (2025)
Figure 10. SuvorexantTablet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5 mgTablets
Figure 12. Product Picture of 10 mgTablets
Figure 13. Product Picture of 15 mgTablets
Figure 14. Product Picture of 20 mgTablets
Figure 15. Product Picture of Other
Figure 16. Global SuvorexantTablet Sales Market Share by Type in 2026
Figure 17. Global SuvorexantTablet Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Approved Originator Product
Figure 19. Product Picture of Approved Generic Product
Figure 20. Product Picture of Generic Under Filing
Figure 21. Global SuvorexantTablet Sales Market Share by Regulatory Status in 2026
Figure 22. Global SuvorexantTablet Revenue Market Share by Regulatory Status (2021-2026)
Figure 23. SuvorexantTablet Consumed in Sleep Onset Insomnia
Figure 24. Global SuvorexantTablet Market: Sleep Onset Insomnia (2021-2026) & (KTablets)
Figure 25. SuvorexantTablet Consumed in Sleep Maintenance Insomnia
Figure 26. Global SuvorexantTablet Market: Sleep Maintenance Insomnia (2021-2026) & (KTablets)
Figure 27. SuvorexantTablet Consumed in Mixed Insomnia
Figure 28. Global SuvorexantTablet Market: Mixed Insomnia (2021-2026) & (KTablets)
Figure 29. SuvorexantTablet Consumed in Clinical Research
Figure 30. Global SuvorexantTablet Market: Clinical Research (2021-2026) & (KTablets)
Figure 31. SuvorexantTablet Consumed in Other
Figure 32. Global SuvorexantTablet Market: Other (2021-2026) & (KTablets)
Figure 33. Global SuvorexantTablet Sale Market Share by Application (2025)
Figure 34. Global SuvorexantTablet Revenue Market Share by Application in 2025
Figure 35. SuvorexantTablet Sales by Company in 2025 (KTablets)
Figure 36. Global SuvorexantTablet Sales Market Share by Company in 2025
Figure 37. SuvorexantTablet Revenue by Company in 2025 ($ millions)
Figure 38. Global SuvorexantTablet Revenue Market Share by Company in 2025
Figure 39. Global SuvorexantTablet Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global SuvorexantTablet Revenue Market Share by Geographic Region in 2025
Figure 41. Americas SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 42. Americas SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 43. APAC SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 44. APAC SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 45. Europe SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 46. Europe SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 48. Middle East & Africa SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 49. Americas SuvorexantTablet Sales Market Share by Country in 2025
Figure 50. Americas SuvorexantTablet Revenue Market Share by Country (2021-2026)
Figure 51. Americas SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 52. Americas SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 53. United States SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC SuvorexantTablet Sales Market Share by Region in 2025
Figure 58. APAC SuvorexantTablet Revenue Market Share by Region (2021-2026)
Figure 59. APAC SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 60. APAC SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 61. China SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 65. India SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe SuvorexantTablet Sales Market Share by Country in 2025
Figure 69. Europe SuvorexantTablet Revenue Market Share by Country (2021-2026)
Figure 70. Europe SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 71. Europe SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 72. Germany SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 73. France SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 74. UK SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa SuvorexantTablet Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 80. Egypt SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of SuvorexantTablet in 2026
Figure 86. Manufacturing Process Analysis of SuvorexantTablet
Figure 87. Industry Chain Structure of SuvorexantTablet
Figure 88. Channels of Distribution
Figure 89. Global SuvorexantTablet Sales Market Forecast by Region (2027-2032)
Figure 90. Global SuvorexantTablet Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global SuvorexantTablet Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global SuvorexantTablet Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global SuvorexantTablet Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global SuvorexantTablet Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of SuvorexantTablet
Figure 2. SuvorexantTablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SuvorexantTablet Sales Growth Rate 2021-2032 (KTablets)
Figure 7. Global SuvorexantTablet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. SuvorexantTablet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. SuvorexantTablet Sales Market Share by Country/Region (2025)
Figure 10. SuvorexantTablet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 5 mgTablets
Figure 12. Product Picture of 10 mgTablets
Figure 13. Product Picture of 15 mgTablets
Figure 14. Product Picture of 20 mgTablets
Figure 15. Product Picture of Other
Figure 16. Global SuvorexantTablet Sales Market Share by Type in 2026
Figure 17. Global SuvorexantTablet Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Approved Originator Product
Figure 19. Product Picture of Approved Generic Product
Figure 20. Product Picture of Generic Under Filing
Figure 21. Global SuvorexantTablet Sales Market Share by Regulatory Status in 2026
Figure 22. Global SuvorexantTablet Revenue Market Share by Regulatory Status (2021-2026)
Figure 23. SuvorexantTablet Consumed in Sleep Onset Insomnia
Figure 24. Global SuvorexantTablet Market: Sleep Onset Insomnia (2021-2026) & (KTablets)
Figure 25. SuvorexantTablet Consumed in Sleep Maintenance Insomnia
Figure 26. Global SuvorexantTablet Market: Sleep Maintenance Insomnia (2021-2026) & (KTablets)
Figure 27. SuvorexantTablet Consumed in Mixed Insomnia
Figure 28. Global SuvorexantTablet Market: Mixed Insomnia (2021-2026) & (KTablets)
Figure 29. SuvorexantTablet Consumed in Clinical Research
Figure 30. Global SuvorexantTablet Market: Clinical Research (2021-2026) & (KTablets)
Figure 31. SuvorexantTablet Consumed in Other
Figure 32. Global SuvorexantTablet Market: Other (2021-2026) & (KTablets)
Figure 33. Global SuvorexantTablet Sale Market Share by Application (2025)
Figure 34. Global SuvorexantTablet Revenue Market Share by Application in 2025
Figure 35. SuvorexantTablet Sales by Company in 2025 (KTablets)
Figure 36. Global SuvorexantTablet Sales Market Share by Company in 2025
Figure 37. SuvorexantTablet Revenue by Company in 2025 ($ millions)
Figure 38. Global SuvorexantTablet Revenue Market Share by Company in 2025
Figure 39. Global SuvorexantTablet Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global SuvorexantTablet Revenue Market Share by Geographic Region in 2025
Figure 41. Americas SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 42. Americas SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 43. APAC SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 44. APAC SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 45. Europe SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 46. Europe SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa SuvorexantTablet Sales 2021-2026 (KTablets)
Figure 48. Middle East & Africa SuvorexantTablet Revenue 2021-2026 ($ millions)
Figure 49. Americas SuvorexantTablet Sales Market Share by Country in 2025
Figure 50. Americas SuvorexantTablet Revenue Market Share by Country (2021-2026)
Figure 51. Americas SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 52. Americas SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 53. United States SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC SuvorexantTablet Sales Market Share by Region in 2025
Figure 58. APAC SuvorexantTablet Revenue Market Share by Region (2021-2026)
Figure 59. APAC SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 60. APAC SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 61. China SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 65. India SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe SuvorexantTablet Sales Market Share by Country in 2025
Figure 69. Europe SuvorexantTablet Revenue Market Share by Country (2021-2026)
Figure 70. Europe SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 71. Europe SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 72. Germany SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 73. France SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 74. UK SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa SuvorexantTablet Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa SuvorexantTablet Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa SuvorexantTablet Sales Market Share by Application (2021-2026)
Figure 80. Egypt SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries SuvorexantTablet Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of SuvorexantTablet in 2026
Figure 86. Manufacturing Process Analysis of SuvorexantTablet
Figure 87. Industry Chain Structure of SuvorexantTablet
Figure 88. Channels of Distribution
Figure 89. Global SuvorexantTablet Sales Market Forecast by Region (2027-2032)
Figure 90. Global SuvorexantTablet Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global SuvorexantTablet Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global SuvorexantTablet Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global SuvorexantTablet Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global SuvorexantTablet Revenue Market Share Forecast by Application (2027-2032)
